Literature DB >> 17869013

Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.

Sarada P Reddy1, Robert L Hong, Suneel Nagda, Bahman Emami.   

Abstract

PURPOSE: To evaluate the effect of tumor bulk on local control and survival of patients with T1 glottic cancer. METHODS AND MATERIALS: Effects of tumor bulk, T-stage, anterior-commissure involvement, treatment duration, and fraction size were analyzed in 208 patients; 136 had small tumors and 72 had bulky tumors. Anterior-commissure was involved in 54 patients. Treatment duration ranged from 39 to 64 days and fraction size ranged from 1.8 to 2.0 Gy. Median follow-up was 5.1 years.
RESULTS: Five-year actuarial local control rates were 86.1% and 91.4% after radiotherapy and salvage laryngectomy. On univariate analysis, local control rates were 92.6% and 73.6% for small and bulky tumors (p = 0.03), 89.6% and 75.9% for patients without and with anterior-commissure involvement (p = 0.01), 92.6% and 75.6% when treatment duration was <or=50 days and >50 days (p = 0.04), and 90.2% and 76.4% with 2 Gy and 1.8 Gy (p = 0.02) per fraction. On multivariate analysis, tumor bulk was the only significant factor that affected local control (p = 0.007). Ultimate local control rates after salvage were 97.1% and 80.5% for patients with small and bulky tumors. Disease-free survival rates at 5 years for small and bulky tumors were 96.3% and 84.7% (p = 0.001). Median duration to recurrence for small tumors was 30 months as compared with 11 months for bulky tumors.
CONCLUSION: Tumor bulk is a highly significant prognostic factor for radiation control of T1 glottic cancer. Patients with bulky tumors had lower local control and disease-free survival rates and shorter duration to recurrence than those with small tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17869013     DOI: 10.1016/j.ijrobp.2007.05.077

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

Review 1.  3D conformal hypofractionated radical radiotherapy in early glottic cancer.

Authors:  Ana Cristina Amado; Laurentiu Bujor; Isabel Monteiro Grillo
Journal:  Rep Pract Oncol Radiother       Date:  2013-05-30

Review 2.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

Review 3.  Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis.

Authors:  Elisabeth Rudolph; Gerhard Dyckhoff; Heiko Becher; Andreas Dietz; Heribert Ramroth
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-10-19       Impact factor: 2.503

Review 4.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

5.  Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shunichi Ishihara; Seiji Kubota; Junji Itoh; Yasushi Fujimoto; Tsutomu Nakashima; Shinji Naganawa
Journal:  Head Neck Oncol       Date:  2010-07-30

6.  Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer.

Authors:  T Rutkowski; A Wygoda; K Składowski; B Hejduk; R Rutkowski; Z Kołosza; B Maciejewski
Journal:  Strahlenther Onkol       Date:  2013-08-29       Impact factor: 3.621

7.  Predictive factors for local control of early glottic squamous cell carcinomas after definitive radiotherapy.

Authors:  Mitsuru Okubo; Tomohiro Itonaga; Tatsuhiko Saito; Sachika Shiraishi; Ryuji Mikami; Akira Sakurada; Shinji Sugahara; Jinho Park; Koichi Tokuuye; Kazuhiro Saito
Journal:  Mol Clin Oncol       Date:  2020-03-30

8.  Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.

Authors:  Mohammad K Khan; Shlomo A Koyfman; Grant K Hunter; Chandana A Reddy; Jerrold P Saxton
Journal:  Radiat Oncol       Date:  2012-11-19       Impact factor: 3.481

9.  Multi-institutional analysis of early glottic cancer from 2000 to 2005.

Authors:  Naoki Hirasawa; Yoshiyuki Itoh; Shinji Naganawa; Shunichi Ishihara; Kazunori Suzuki; Kazuyuki Koyama; Takayuki Murao; Akiko Asano; Yoshihito Nomoto; Yoshimi Horikawa; Masahiro Sasaoka; Yasunori Obata
Journal:  Radiat Oncol       Date:  2012-08-01       Impact factor: 3.481

10.  Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1.

Authors:  Yuuki Takase; Yoshiyuki Itoh; Kazuhiro Ohtakara; Mariko Kawamura; Junji Ito; Yumi Oie; Tamami Ono; Yutaro Sasaki; Ayumi Nishida; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2021-05       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.